Browsing by Yonsei Author : Rha, Sun Young

Name:
라선영 [Rha, Sun Young] http://orcid.org/0000-0002-2512-4531
Department :
College of Medicine - Dept. of Internal Medicine
Scopus ID :
(7006023235)

Keyword Cloud

Researcher Network

This table browses all dspace content
Issue DateTitleYonsei Author(s)Type
2019S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial 김효송, 노성훈, 라선영, 정민규, 정인경, 정재호, 정현철, 형우진Article
2019Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial 라선영, 정현철Article
2019Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancer강버들, 금웅섭, 김은혜, 김현기, 김형일, 김효송, 노성훈, 라선영, 박준철, 범승훈, 손태일, 신성관, 이상길, 이용찬, 임준석, 장지석, 정민규, 정인경, 정재호, 정현수, 정현철, 최윤영, 형우진Article
2019The clinical implications of FDG-PET/CT differ according to histology in advanced gastric cancer. 노성훈, 라선영, 안중배, 윤미진, 조응혁, 형우진Article
2019Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial 김민환, 김현기, 김형일, 김효송, 노성훈, 라선영, 박형순, 범승훈, 손태일, 정민규, 정인경, 정재호, 정현철, 최윤영, 형우진Article
2019Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma김경식, 김상겸, 김성훈, 김승현, 김지형, 김효송, 노성훈, 라선영, 박형순, 서진석, 신규호, 안중배, 이영한, 정현철, 최영득, 한정우, 허수진, 허혁Article
2019Behaviors and Attitudes toward the Use of Complementary and Alternative Medicine among Korean Cancer Patients 라선영, 정현철Article
2019Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients 김상겸, 라선영, 정현철Article
2018Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma. 김경식, 김성훈, 김은경, 김효송, 노성훈, 라선영, 서진석, 안중배, 이영한, 정현철, 최영득, 한정우, 허혁Article
2018Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy 김형일, 김효송, 노성훈, 라선영, 백송이, 범승훈, 손태일, 임준석, 정민규, 정재호, 정희철, 최승호, 최윤영, 형우진Article
2018Rab25 augments cancer cell invasiveness through a beta1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin라선영, 정재호Article
2018Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor김태수, 라선영, 정현철, 정희철Article
2018Retrospective analysis of palliative chemotherapy for the patients with bladder adenocarcinoma: Korean Cancer Study Group Genitourinary and Gynecology Cancer Committee. 김효송, 라선영Article
2018The prognostic value of volume-based parameters using<sup>18</sup>F-FDG PET/CT in gastric cancer according to HER2 status김효송, 라선영, 박지수, 범승훈, 윤미진, 이충근, 정민규, 정현철, 조응혁Article
2018A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and Chemotherapy김승섭, 김효송, 남정모, 라선영, 박경수, 정민규, 정재호, 정현철, 채동우Article
2018Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial김지형, 김형일, 김효송, 노성훈, 라선영, 박형순, 백송이, 범승훈, 손태일, 임준석, 정민규, 정재호, 정현철, 최은아, 허수진, 형우진Article
2018Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG)강윤구, 라선영, 정민규, 조재용Article
2018Genetic Alterations among Korean Melanoma Patients Showing Tumor Heterogeneity: A Comparison between Primary Tumors and Corresponding Metastatic Lesions. 노미령, 라선영, 신상준, 오병호, 이시형, 정기양Article
2018MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis.김한상, 김현기, 라선영, 정현철Article
2018BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression 라선영, 안중배Article
2018CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer 김남규, 김태일, 라선영, 박규현, 신상준, 안중배, 이강영Article
2018Casein Kinase 2 Inhibitor, CX-4945, as a Potential Targeted Anticancer Agent in Gastric Cancer김태수, 라선영, 박규현, 정민규, 정현철Article
2018Regulation of proliferation and invasion by the IGF signalling pathway in Epstein-Barr virus-positive gastric cancer 라선영, 정현철Article
2018Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma라선영Article
2018Renal Cell Carcinoma Is Abrogated by p53 Stabilization through Transglutaminase 2 Inhibition 라선영Article
2018Reconsideration of sample size and power calculation for overall survival in cancer clinical trials 남정모, 라선영, 정인경Article
2018Real-Time Tumor Gene Expression Profiling to Direct Gastric Cancer Chemotherapy: Proof-of-Concept "3G" Trial김효송, 라선영, 정민규, 정현철Article
2018The Benefit of Pro Re Nata Antiemetics Provided With Guideline-Consistent Antiemetics in Delayed Nausea Control김건민, 김혜련, 라선영, 손주혁Article
2017A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid Tumors라선영, 정현철Article
2017Integration of radiotherapy and chemotherapy for abdominal lymph node recurrence in gastric cancer금웅섭, 김효송, 라선영, 윤홍인, 이용찬, 임준석, 형우진Article
2017Prevalence and prognostic implications of psychological distress in patients with gastric cancer 김건민, 김경란, 김혜련, 노성훈, 라선영, 송수경, 정현철Article
2017Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents.강원준, 라선영, 윤미진, 조응혁, 최영득Article
2017Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia 김지현, 김현기, 노성훈, 라선영, 박소희, 안중배, 전홍재, 정현철, 정희철, 형우진Article
2017Different subtypes of epithelioid sarcoma and their clinical implication: long-term multi-institutional experience with a rare sarcoma김경식, 김민환, 김효송, 라선영, 최영득Article
2017ABCB1 2677G>T/A variant enhances chemosensitivity to anti-cancer agents acting on microtubule dynamics through LAMP1 inhibition김태수, 라선영, 안중배, 정현철, 정희철Article
2017Telomerase reverse transcriptase (TERT) promoter mutations in Korean melanoma patients 노미령, 라선영, 박규현, 신상준, 정기양Article
2017Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer 금웅섭, 김현기, 김형일, 김효송, 노성훈, 라선영, 박규현, 박준철, 배수진, 백순명, 범승훈, 손태일, 신성관, 이상길, 이용찬, 이은영, 이한나, 임준석, 정민규, 정재호, 정현철, 최윤영, 형우진Article
2017Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer 김태수, 노재경, 라선영, 박규현, 신상준, 안중배, 정현철, 정희철Article
2017Characterizing the outcomes of metastatic papillary renal cell carcinoma라선영Article
2017Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma라선영Article
2017Epigenomic Promoter Alterations Amplify Gene Isoform and Immunogenic Diversity in Gastric Adenocarcinoma라선영Article
2017A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors김건민, 라선영, 신상준, 안중배, 정현철Article
2017PTEN loss and level of HER2 amplification is associated with trastuzumab resistance and prognosis in HER2-positive gastric cancer 김주훈, 김태수, 라선영, 박형순, 이충근, 정현철, 허수진Article
2017Modulation of HAT activity by the BRCA2 N372H variation is a novel mechanism of paclitaxel resistance in breast cancer cell lines김태수, 라선영, 정현철, 정희철Article
2017Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancer금웅섭, 김효송, 노성훈, 라선영, 윤홍인, 이용찬, 임준석, 장지석, 형우진Article
2017Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer 강석민, 김지형, 김효송, 라선영, 박지수, 박형순, 범승훈, 심지영, 이충근, 정민규, 정현철, 허수진, 홍그루Article
2017Symptom clusters during palliative chemotherapy and their influence on functioning and quality of life라선영Article
2017Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC 라선영Article
2017Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab 김승섭, 김현기, 김효송, 라선영, 박소희, 이충근, 임준석, 정민규, 정현철, 허수진Article
2016Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium라선영Article

Browse